We report an association of pancreatic cancer with DNA damage and associations with specific polymorphisms in genes involved in metabolism (CYP2A6), inflammation (TNFA), and DNA damage and repair (ERCC4). This evidence concerns the gene CYP2A6 and pancreatic neoplasm.